Members |
targetComponentId |
Ca cervix screening NOS |
Cancer cervix screening status (finding) |
Ca cervix screening NOS |
Screening for malignant neoplasm of cervix |
Ca cervix uteri NOS |
Malignant tumour of cervix |
Ca cervix uteri NOS |
Malignant tumour of cervix |
Ca colon NOS |
Malignant tumour of colon |
Ca colon NOS |
Malignant tumour of colon |
Ca esophagus NOS |
Malignant tumour of oesophagus |
Ca larynx - NOS |
Malignant tumour of larynx |
Ca larynx - NOS |
Malignant tumour of larynx |
Ca lip, oral, pharynx NOS |
Malignant neoplasm of lip, oral cavity and pharynx |
Ca lip, oral, pharynx NOS |
Malignant neoplasm of lip, oral cavity and pharynx |
Ca liver/biliary system NOS |
Carcinoma liver and/or biliary system (disorder) |
Ca liver/biliary system NOS |
Carcinoma liver and/or biliary system (disorder) |
Ca oesophagus NOS |
Malignant tumour of oesophagus |
Ca pancreas NOS |
Malignant tumor of pancreas |
Ca pancreas NOS |
Malignant tumor of pancreas |
Ca rectum + Ca anus NOS |
Malignant neoplasm of anorectum (disorder) |
Ca rectum + Ca anus NOS |
Malignant neoplasm of anorectum (disorder) |
Ca skin - other NOS |
Malignant neoplasm of skin (disorder) |
Ca skin - other NOS |
Malignant neoplasm of skin (disorder) |
Ca stomach NOS |
Malignant tumor of stomach |
Ca stomach NOS |
Malignant tumor of stomach |
Ca uterus NOS: [carcinoma] or [cancer] |
Malignant neoplasm of uterus (disorder) |
Ca uterus NOS: [carcinoma] or [cancer] |
Malignant neoplasm of uterus (disorder) |
Cabbage - dietary |
Cabbage (substance) |
Cabergoline [parkinsons] |
Product containing cabergoline (medicinal product) |
Caesarean delivery - delivered |
Deliveries by caesarean |
Caffeine and sodium benzoate injection |
Product containing caffeine and sodium benzoate (medicinal product) |
Caffeine containing substance - non-pharmaceutical |
Caffeine |
Café-au-lait spots and ring chromosome 11 |
Ring chromosome 11 syndrome |
Calcaneum X-ray |
Plain X-ray of calcaneum |
Calcaneum X-ray |
Plain X-ray of calcaneum |
Calcipotriene 0.005%/betamethasone 0.064% topical suspension |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Calcitonin, salmon 100unit/mL injection solution 1mL vial |
Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
Calcitonin, salmon 200iu/mL spray |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
Calcitonin, salmon 200unt/mL injection |
Salmon calcitonin 200 unit/mL solution for injection |
Calcitonin, salmon 200unt/mL injection solution 2mL vial |
Salmon calcitonin 200 unit/mL solution for injection |
Calcium analyte |
Calcium |
Calcium antacid |
Calcium compound |
Calcium carbonate+cholecalciferol 1.25g/11micrograms/sachet granules |
Calcium carbonate 6.25 mg/mL and colecalciferol 2.2 unit/mL oral solution |
Calcium chloride 10% injection solution 10mL prefilled syringe |
Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 0.3mL prefilled syringe |
Hydroxyapatite only product in parenteral dose form |
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 1.3mL prefilled syringe |
Hydroxyapatite only product in parenteral dose form |
Calcium phosphate+colecalciferol 3100mg/20micrograms/sachet powder for oral suspension |
Calcium phosphate and colecalciferol only product |
Calculation of stenosis of internal carotid artery using the NASCET method |
Calculation of degree of stenosis of internal carotid artery using the diameter of the distal internal carotid artery lumen as denominator |
Calculation of stenosis of internal carotid artery using the diameter of the distal internal carotid artery lumen as denominator |
Calculation of degree of stenosis of internal carotid artery using the diameter of the distal internal carotid artery lumen as denominator |
Calculus - composition |
Calculus chemical composition - finding |
Calculus analysis NOS |
Calculus analysis |
Calculus analysis NOS |
Calculus analysis |
Calculus chem. comp. NOS |
Determination of calculus chemical composition |
Calculus chemical composition NOS |
Determination of calculus chemical composition |
Calculus exam. general |
Calculus examination |
Calculus examination NOS |
Calculus examination |
Calculus examination NOS |
Calculus examination |
Calculus examination general |
Calculus examination |
Calculus gen. exam. NOS |
Calculus examination |
Calculus general examination NOS |
Calculus examination |
Calculus of bile duct with acute cholecystitis without obstruction |
Bile duct calculus with acute cholecystitis |
Calculus of bile duct with chronic cholecystitis without obstruction |
Calculus of bile duct with chronic cholecystitis |
Calculus of bile duct without obstruction |
Calculus of bile duct |
Calculus of common bile duct with acute cholecystitis without obstruction |
Calculus of common bile duct with acute cholecystitis |
Calculus of common bile duct with chronic cholecystitis without obstruction |
Calculus of common bile duct with chronic cholecystitis (disorder) |
Calculus of common bile duct without obstruction |
Common bile duct calculus |
Calculus of common duct without obstruction |
Common bile duct calculus |
Calfactant intratracheal suspension 6mL vial |
Product containing only calfactant (medicinal product) |
Caliber-persistent labial artery |
Caliber persistent labial artery (disorder) |
Calicivirus group |
Family Caliciviridae (organism) |
Calliphora erythrocephala |
Calliphora vicina |
Callitrogae |
Genus Cochliomyia (organism) |
Caloric intake, function (observable entity) |
Energy intake (observable entity) |
Caloscypha fulgens |
Caloscypha fulgens (organism) |
Calymmatobacterium granulomatis |
Klebsiella granulomatis (organism) |
Camouflaging preparations adverse reaction |
Adverse reaction (disorder) |
Campylobacter cinaedi |
Helicobacter cinaedi |
Campylobacter fennelliae |
Helicobacter fennelliae |
Campylobacter laridis |
Campylobacter lari |
Campylobacter laridis rRNA |
Campylobacter lari rRNA |
Campylobacter laridis rRNA assay |
Campylobacter lari rRNA assay |
Campylobacter nitrofigilis |
Arcobacter nitrofigilis (organism) |
Canakinumab 150mg powder for injection solution |
Canakinumab only product |
Canal preparation and fitting of preformed dowel or post |
Preparation of root canal of tooth and insertion of preformed post |
Cancer care plan |
Cancer care plan |
Cancer care plan |
Cancer care plan |
Cancer care plan |
Cancer care plan |
Cancer care review |
Cancer care review (procedure) |
Cancer cervix - screening done |
Screening for malignant neoplasm of cervix done (situation) |
Candida famata |
Debaryomyces hansenii |
Candida famata |
Debaryomyces hansenii |
Candida guilliermondii var guilliermondii |
Meyerozyma guilliermondii (organism) |
Candida humicola |
Vanrija humicola (organism) |
Candida krusei var. vanlaeriana |
Pichia membranifaciens (organism) |
Candida lactosa |
Saccharomycopsis fibuligera (organism) |
Candida lipolytica |
Yarrowia lipolytica |
Candida pseudotropicalis |
Kluyveromyces marxianus |
Candidiasis of other specified sites |
Candidiasis |
Candidiasis of other urogenital sites |
Candidiasis of urogenital site |
Canine cortical hyperostosis |
Disorder of bone (disorder) |
Canis familiaris |
Canis lupus subspecies familiaris (organism) |
Canis rufus |
Canis lupus subspecies rufus (organism) |
Cannabinoid |
Cannabis (substance) |
Cannabinoid - non-pharmaceutical |
Cannabis (substance) |